Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters








Language
Year range
1.
Rev. bras. cir. cardiovasc ; 33(6): 553-558, Nov.-Dec. 2018. tab, graf
Article in English | LILACS | ID: biblio-977479

ABSTRACT

Abstract Objective: The aim of this study was to compare the efficacy of two different papaverine concentrations (0.5 mg/ml and 2 mg/ml) for vasospasm prevention and their impact on endothelium integrity. Methods: We have studied distal segments of radial arteries obtained by no-touch technique from coronary artery bypass graft (CABG) patients (n=10). The vasodilatory effect of papaverine (concentrations of 0.5 mg/ml and 2 mg/ml) was assessed in vitro, in isometric tension studies using ex vivo myography (organ bath technique) and arterial rings precontracted with potassium chloride (KCl) and phenylephrine. The impact of papaverine on endothelial integrity was studied by measurement of the percentage of vessel's circumference revealing CD34 endothelial marker. Results: 2 mg/ml papaverine concentration showed stronger vasodilatatory effect than 0.5 mg/ml, but it caused significantly higher endothelial damage. Response to KCl was 7.35±3.33 mN for vessels protected with papaverine 0.5 mg/ml and 2.66±1.96 mN when papaverine in concentration of 2 mg/ml was used. The histological examination revealed a significant difference in the presence of undamaged endothelium between vessels incubated in papaverine 0.5 mg/ml (72.86±9.3%) and 2 mg/ml (50.23±13.42%), P=0.002. Conclusion: Papaverine 2 mg/ml caused the higher endothelial damage. Concentration of 0.5 mg/ml caused better preservation of the endothelial lining.


Subject(s)
Humans , Male , Female , Aged , Papaverine/administration & dosage , Vasodilator Agents/administration & dosage , Coronary Artery Disease/surgery , Endothelium, Vascular/drug effects , Radial Artery/drug effects , Coronary Vasospasm/prevention & control , Papaverine/adverse effects , Papaverine/pharmacology , Vasoconstriction/drug effects , Vasodilation/drug effects , Vasodilator Agents/adverse effects , Vasodilator Agents/pharmacology , Coronary Artery Disease/physiopathology , Coronary Artery Bypass/methods
SELECTION OF CITATIONS
SEARCH DETAIL